/4881.T
4881.T Stock - FunPep Company Limited
Healthcare|BiotechnologyJPX
$77.00+1.32%
+$1.00 (+1.32%) • Dec 24
53
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.4
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.89
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $84.70
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4881.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$76.23 – $77.77
TARGET (TP)$88.55
STOP LOSS$70.84
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.77
52W High$163.00
52W Low$75.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $6.13M | $530,000 | $1.07M | $126.87M | $2.97M |
| Gross Profit | $-37,859,000 | $-680,287,000 | $-12,839,000 | $-535,625,000 | $-362,014,000 |
| Gross Margin | -617.9% | -128356.0% | -1203.3% | -422.2% | -12189.0% |
| Operating Income | $-901,758,000 | $-994,108,000 | $-1,169,069,000 | $-745,044,000 | $-564,598,000 |
| Net Income | $-889,092,000 | $-933,416,000 | $-1,172,515,000 | $-682,265,000 | $-507,930,000 |
| Net Margin | -14511.0% | -176116.2% | -109888.9% | -537.8% | -17102.0% |
| EPS | $-31.97 | $-39.63 | $-61.04 | $-39.58 | $-40.37 |
Company Overview
FunPep Company Limited engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides. The company is developing SR-0379, a functional peptide for skin ulcer; FPP003, an antibody-inducing peptide that is in Phase II clinical study for the treatment of psoriasis in Australia, as well as phase II clinical trial for ankylosing spondylitis in Japan; and FPP004X, an antibody-inducing peptide for pollinosis. It is also developing FPP006, a corona peptide vaccine; and FPP005, a antibody including peptide for psoriasis. FunPep Company Limited was incorporated in 2013 and is based in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4881.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-8.38
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 9, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | — | $-8.38 | — | — |
Q2 2025 | May 14, 2025 | — | $-18.24 | — | — |
Q1 2025 | Feb 12, 2025 | — | $-10.18 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-6.39 | — | — |
Q3 2024 | Aug 8, 2024 | — | $-8.10 | — | — |
Q2 2024 | May 13, 2024 | — | $-6.88 | — | — |
Q1 2024 | Feb 14, 2024 | — | $-7.74 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-6.68 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-10.22 | — | — |
Q2 2023 | May 15, 2023 | — | $-15.47 | — | — |
Q1 2023 | Feb 14, 2023 | — | $-19.36 | — | — |
Q3 2022 | Sep 29, 2022 | — | $-15.82 | — | — |
Q3 2022 | Aug 12, 2022 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4881.T
What is 4881.T's current stock price?
FunPep Company Limited (4881.T) is currently trading at $77.00 per share. The stock has moved +1.32% today.
What is the analyst price target for 4881.T?
No analyst price targets are currently available for this stock.
What sector is FunPep Company Limited in?
FunPep Company Limited operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the JPX exchange.
What is 4881.T's market cap?
FunPep Company Limited has a market capitalization of $3.12 billion, making it a mid-cap company.
Does 4881.T pay dividends?
No, FunPep Company Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector2342.T
Trans Genic Inc.
$254.00
Mkt Cap: $4.2B
4570.T
Immuno-Biological Laboratories Co., Ltd.
$1404.00
Mkt Cap: $13.1B
4572.T
Carna Biosciences, Inc.
$415.00
Mkt Cap: $7.9B
4576.T
D. Western Therapeutics Institute, Inc.
$93.00
Mkt Cap: $4.1B
4591.T
Ribomic Inc.
$74.00
Mkt Cap: $3.5B
4596.T
Kubota Pharmaceutical Holdings Co., Ltd.
$42.00
Mkt Cap: $2.5B
4598.T
Delta-Fly Pharma, Inc.
$500.00
Mkt Cap: $5.7B
4884.T
Kringle Pharma, Inc.
$378.00
Mkt Cap: $2.6B
6034.T
MRT Inc.
$622.00
Mkt Cap: $3.5B
9776.T
Sapporo Clinical Laboratory Inc.
$1966.00
Mkt Cap: $6.1B
Explore stocks similar to 4881.T for comparison